ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Digital Microscope Blood Test Identifies Circulating Tumor Cells

February 24, 2012

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995